
Articles
-
1 week ago |
news.bloomberglaw.com | Hari Govind |Jeremy Cooke
(Updates Charles River share move, adds other peers, AI movers, more details from FDA.) The FDA said it plans to phase out animal testing requirements for monoclonal antibodies and other drugs, replacing them with “more effective, human-relevant methods.” Shares in Charles River Laboratories, a leading provider of research animal models, plunged by a one-day record of 28% to the lowest since March 2020 Among other contract-research peers, LabCorp closed lower by 5.2%, while microcap stock...
-
1 week ago |
news.bloombergtax.com | Hari Govind |Jeremy Cooke
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
2 weeks ago |
news.bloomberglaw.com | Hari Govind
Jazz Pharmaceuticals said its Ireland subsidiary agreed to pay $145 million to settle class actions related to indirect Xyrem purchasers. • The company will use cash on hand to fund the settlementTo view the source of this information, clickTo contact the reporter on this story: in San Francisco at [email protected] contact the editor responsible for this story: at [email protected]© 2025 Bloomberg L.P. All rights reserved. Used with permission.
-
3 weeks ago |
news.bloomberglaw.com | Hari Govind
Siemens agreed to acquire R&D software maker Dotmatics from Insight Partners for about $5.1 billion.
-
3 weeks ago |
news.bloombergtax.com | Hari Govind
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →